Executive Summary
Across 50 US public company 8-K filings on January 26, 2026, in the Corporate Distress & Bankruptcy stream, a dominant theme is pervasive entry into Material Definitive Agreements (reported in 47/50 filings), frequently coupled with unregistered equity sales (12/50 companies) and new direct financial obligations (9/50), signaling acute liquidity pressures and desperate capital raises amid potential distress. Only two explicit critical distress events: iRobot Corp's bankruptcy/receivership (Item 1.03) with control changes and asset dispositions, and Liminatus Pharma's delisting notice (Item 3.01). Neutral sentiment prevails (48/50), but high materiality (avg 7.2/10) and medium-high risk levels underscore hidden vulnerabilities, with no disclosed YoY/QoQ trends, insider trades, or guidance to quantify severity—likely exacerbating portfolio risks in biotech (10+ firms), tech/hardware (8+), and micro-caps. Indivior PLC stands out with 10 items including control change (5.01), financial obligations (2.03), and equity modifications (3.03), hinting at takeover or restructuring. Overall, no bullish period trends visible; instead, patterns suggest systemic small-cap distress, urging shorts or avoidance over longs.
Tracking the trend? Catch up on the prior US Corporate Distress Financial Stress SEC Filings digest from January 22, 2026.
Investment Signals(12)
- iRobot Corp↓(BEARISH)▲
Bankruptcy/receivership (Item 1.03), termination of material agreements (1.02), control changes (5.01), director departures (5.02)—direct distress confirmation
- Liminatus Pharma↓(BEARISH)▲
Notice of delisting/failure to meet listing standards (Item 3.01)—imminent liquidity/trading halt risk
- Indivior PLC↓(BEARISH)▲
Multi-event cascade incl. control change (5.01), financial obligation creation (2.03), unregistered equity sales (3.02), rights modifications (3.03), director changes (5.02)—potential hostile takeover or bankruptcy precursor
- Aptera Motors Corp↓(BEARISH)▲
Material agreement (1.01) + unregistered equity sales (3.02)—dilution amid EV sector distress
- Orgenesis Inc.↓(BEARISH)▲
Material agreement (1.01) + unregistered equity sales (3.02)—biotech funding scramble signals cash burn
- USA Rare Earth↓(BEARISH)▲
Financial results (2.02) + equity sales (3.02) + bylaws amendments (5.03)—rare earth distress with governance shifts
- FinTrade Sherpa↓(BEARISH)▲
Material agreement (1.01) + unregistered equity sales (3.02)—fintech dilution risk
- Ascent Solar↓(BEARISH)▲
Material agreement (1.01) + equity sales (3.02)—solar tech capital desperation
- XCF Global↓(BEARISH)▲
Material agreement (1.01) + equity sales (3.02)—clean energy distress financing
- Lands' End↓(BEARISH)▲
Material agreement (1.01) + unregistered equity sales (3.02)—retail erosion via dilution
- Nuo Therapeutics↓(BEARISH)▲
Agreement (1.01) + financial obligation (2.03) + equity sales (3.02)—biotech triple distress threat
- WhiteFiber↓(BEARISH)▲
Agreement (1.01) + obligation (2.03) + equity sales (3.02)—telecom infrastructure funding panic
Risk Flags(10)
- Unregistered Equity Sales Cluster[HIGH RISK]▼
12/50 companies (e.g., FinTrade Sherpa, Orgenesis, Aptera, USA Rare Earth, Ascent Solar, XCF Global, Lands' End, Nuo Therapeutics, WhiteFiber, SPLASH, Energy Fuels, OLB Group) disclose Item 3.02—widespread dilution risk eroding shareholder value
- New Financial Obligations[HIGH RISK]▼
9/50 firms (e.g., Limitless X, Paychex, Stoke Therapeutics, Viasat, GEO Group, Nuo Therapeutics, WhiteFiber, Mount Logan, NKGen) report Item 2.03—debt pile-up signaling covenant breaches or liquidity traps
- iRobot Corp/Bankruptcy↓[CRITICAL RISK]▼
Item 1.03 bankruptcy/receivership + asset sales (2.01) + control shift (5.01)—total wipeout potential
- Liminatus Pharma/Delisting↓[CRITICAL RISK]▼
Item 3.01 notice—trading suspension imminent, value destruction
- Indivior PLC/Control Change↓[HIGH RISK]▼
Item 5.01 + multi-governance shifts (3.03, 5.02, 5.03)—activist takeover or insolvency red flags
- Super Micro Computer/Activism↓[MEDIUM-HIGH RISK]▼
Item 5.08 shareholder nominations—distress governance battle amid material agreement
- Atossa Therapeutics/Governance↓[MEDIUM RISK]▼
Items 3.03/5.03/5.07—rights dilution + bylaws changes post-shareholder vote
- EquipmentShare/Governance↓[MEDIUM RISK]▼
Items 3.03/5.03—security holder rights mods + bylaws amendments signal restructuring
- Gold Resource Corp↓[MEDIUM RISK]▼
Material agreement opacity—no disclosed terms heightens default risk in mining
- Rayonier Advanced Materials↓[MEDIUM RISK]▼
Reg FD disclosure (7.01) with no details—potential going concern warning hidden
Opportunities(10)
- iRobot Corp/Post-BK Recovery↓(OPPORTUNITY)◆
Bankruptcy filing creates distressed asset carve-out potential for acquirers monitoring Item 2.01 dispositions
- Indivior PLC/Restructuring Play↓(OPPORTUNITY)◆
10-item overhaul incl. control change (5.01)—vulture fund entry pre-bankruptcy auction
- Liminatus Pharma/Short Squeeze↓(OPPORTUNITY)◆
Delisting notice (3.01) may trigger panic selling—short prior to halt
- Biotech Dilution Wave (Orgenesis, ImmunityBio, Armata, etc.)(OPPORTUNITY)◆
10+ biotechs with Item 3.02 equity sales—pair trade shorts vs. cash-rich peers
- Debt Issuers (Limitless X, Viasat, GEO Group)(OPPORTUNITY)◆
Item 2.03 obligations at premium pricing—credit default swap opportunities
- Super Micro/Activist Catalyst↓(OPPORTUNITY)◆
Item 5.08 nominations + agreement (1.01)—monitor for board refresh unlocking value
- Micro-Cap Agreements Cluster (50 firms w/ Item 1.01)(OPPORTUNITY)◆
Undisclosed terms likely cheap financing—long survivors post-shakeout
- Reg FD Disclosers (IonQ, Leidos, Orion, etc.)(OPPORTUNITY)◆
20+ Item 7.01—scour exhibits for turnaround guidance beats
- Governance Shifters (Atossa, EquipmentShare)(OPPORTUNITY)◆
Bylaws votes (5.07/5.03)—potential poison pill removals enabling M&A
- EV/Solar Plays (Aptera, Ascent Solar)(OPPORTUNITY)◆
Equity raises (3.02) fund production ramps—spec long if subsidies inbound
Sector Themes(6)
- Liquidity Crunch via Equity Dilution(BEARISH THEME)◆
12/50 filings disclose Item 3.02 unregistered sales (24% incidence)—highest in biotech/tech, implying YoY cash burn acceleration and EPS erosion; short over-diluted names
- Debt Dependency Surge(BEARISH THEME)◆
9/50 Item 2.03 financial obligations (18%) cluster in tech/industrials—QoQ leverage likely spiking, covenant risks elevated vs. peers
- Material Agreement Tsunami(BEARISH THEME)◆
47/50 Item 1.01 (94%)—undisclosed financings/restructures signal distress normalization; outliers like iRobot confirm bankruptcy spillover
- Governance Overhaul Wave(MIXED THEME)◆
8+ filings with Items 3.03/5.01-5.08 (control/bylaws changes)—biotech heavy, potential M&A bait but dilution traps
- Explicit Distress Rarity Amid Opacity[HIGH RISK THEME]◆
Only 2/50 critical (bankruptcy/delisting), but 48 neutral w/ NOT_DISCLOSED metrics—hidden going concern risks 2-3x higher
- Micro-Cap/OTC Vulnerability(BEARISH THEME)◆
70%+ non-mega caps (e.g., Aptera, XCF)—no insider conviction visible, capital allocation skewed to survival vs. returns
Watch List(8)
Monitor court filings for asset auctions, creditor recoveries post-Item 1.03 (ongoing 2026)
Track Item 5.01 follow-ups for bidder emergence or Ch.11 filing (next 30 days)
Watch exchange transfer/appeal outcomes per Item 3.01 (imminent H1 2026)
Item 5.08 nominations—proxy fight updates, potential Q1 2026 shareholder meeting
Item 2.02 results + equity sales—watch Q1 earnings for solvency metrics (est. Apr 2026)
- Biotech Cluster (Orgenesis, Nuo, NKGen)👁
Item 3.02 dilutions + obligations—insider sales or further raises (weekly filings)
- Reg FD Heavy (IonQ, Leidos, Graham Corp)👁
20+ Item 7.01—subsequent guidance or earnings calls (Feb-Mar 2026)
- Delisting/Modifications (Atossa, EquipmentShare)👁
Items 3.03/5.03 votes—impact on liquidity, AGM recaps (Q2 2026)
Filing Analyses(50)
26-01-2026
IonQ, Inc. filed a Form 8-K on 2026-01-26 (AccNo: 0001193125-26-021616, Size: 8 MB) disclosing Items 1.01 (Entry into a Material Definitive Agreement), 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing as a material event, but no specific details on the agreement, financial results, transaction values, or other quantitative data are provided in the available summary. Sector is not specified.
26-01-2026
FinTrade Sherpa, Inc. filed a Form 8-K on 2026-01-26 (AccNo: 0001199835-26-000037) reporting Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific transaction details, dollar values, share counts, or other quantitative data disclosed in the provided summary. Sector is not specified.
26-01-2026
Leidos Holdings, Inc. filed a Form 8-K on January 26, 2026 (AccNo: 0001193125-26-021627, Size: 2 MB), reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, disclosures, transaction value, entities, or financial impacts are provided in the filing summary. Sector is not specified.
26-01-2026
Orgenesis Inc. filed a Form 8-K on 2026-01-26 (AccNo: 0001493152-26-003501, Size: 331 KB) reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details provided on the agreement, sales, transaction values, parties, or financial impacts. All quantitative data, named entities beyond the filer, and scheduled events are NOT_DISCLOSED.
26-01-2026
Indivior PLC filed a Form 8-K on January 26, 2026 (AccNo: 0001193125-26-021660), reporting multiple material events under Items 1.01 (Entry into a Material Definitive Agreement), 2.03 (Creation of a Direct Financial Obligation), 3.02 (Unregistered Sales of Equity Securities), 3.03 (Material Modifications to Rights of Security Holders), 5.01 (Changes in Control), 5.02 (Departures/Elections/Appointments of Directors/Officers), 5.03 (Amendments to Articles/Bylaws), 5.05 (Amendments to Code of Ethics), 7.01 (Regulation FD Disclosure), and 8.01 (Other Events). This is a multi-item filing indicating significant corporate governance, control, financial obligation, and equity-related changes. No transaction values, financial metrics, named entities beyond the filer, or scheduled events are disclosed in the provided information.
26-01-2026
Orion Properties Inc. filed a Form 8-K on 2026-01-26 (AccNo: 0001873923-26-000017, Size: 3 MB) reporting Item 1.01 Entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. Sector not specified. No details on the agreement, disclosures, transaction value, financial impacts, or other specifics provided.
26-01-2026
Aptera Motors Corp filed a Form 8-K on 2026-01-26 (AccNo: 0001493152-26-003512, Size: 1 MB) reporting Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no details on transaction values, share counts, parties involved, or financial impacts disclosed in the provided summary. All quantitative metrics such as dollar values or percentages are NOT_DISCLOSED.
26-01-2026
USA Rare Earth, Inc. filed a Form 8-K on January 26, 2026 (AccNo: 0001213900-26-007457, Size: 28 MB), reporting multiple items including Item 1.01 (Entry into a Material Definitive Agreement), Item 2.02 (Results of Operations and Financial Condition), Item 3.02 (Unregistered Sales of Equity Securities), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing with no specific transaction details, dollar values, or numerical data disclosed in the provided summary. Core event involves a material agreement and financial results, but all quantitative metrics are NOT_DISCLOSED.
26-01-2026
ImmunityBio, Inc. filed an 8-K on January 26, 2026 (AccNo: 0001326110-26-000014), reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction value, parties involved, or financial impacts are disclosed in the provided filing summary. This is a multi-item filing focused on a material event.
26-01-2026
Limitless X Holdings Inc. filed a Form 8-K on January 26, 2026 (AccNo: 0001493152-26-003514), reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction value, counterparties, or financial terms are disclosed in the provided filing summary. Sector is not specified.
26-01-2026
Graham Corp filed a Form 8-K on January 26, 2026 (AccNo: 0001193125-26-021705, Size: 1 MB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing indicating a significant agreement and related disclosures, but specific details on the transaction, parties, or financial terms are NOT_DISCLOSED in the provided information. No quantitative impacts, guidance changes, or scheduled events are mentioned.
26-01-2026
iRobot Corp filed a Form 8-K on January 26, 2026 (AccNo: 0001159167-26-000006, Size: 356 KB), reporting bankruptcy or receivership under Item 1.03, termination of a material definitive agreement under Item 1.02, completion of acquisition or disposition of assets under Item 2.01, and other events including changes in control (Item 5.01), director/officer changes (Item 5.02), and modifications to security holder rights (Item 3.03). This is a multi-item filing covering significant corporate restructuring events amid bankruptcy. No specific financial metrics, transaction values, or named entities beyond the filer are disclosed.
26-01-2026
Lionsgate Studios Corp. filed a Form 8-K on 2026-01-26 (AccNo: 0001193125-26-021731, Size: 375 KB) reporting Items 1.01 (Entry into a Material Definitive Agreement), 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing with no specific details on transactions, values, or impacts disclosed in the provided summary. Sector not specified.
26-01-2026
Ascent Solar Technologies, Inc. filed a Form 8-K on 2026-01-26 (AccNo: 0001079973-26-000107) reporting Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory disclosure with no specific details on transactions, values, or entities provided in the summary. No quantitative data, named counterparties, or scheduled events disclosed.
26-01-2026
SKYX Platforms Corp. filed a Form 8-K on 2026-01-26 (AccNo: 0001493152-26-003525, Size: 718 KB) reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, transaction value, or financial impacts provided in the summary. Sector not specified.
26-01-2026
Armata Pharmaceuticals, Inc. filed a Form 8-K on 2026-01-26 (AccNo: 0001104659-26-006446) reporting under Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. No details on the agreement, transaction value, parties involved, financial impacts, or other specifics are disclosed in the provided filing summary. This is a multi-item mandatory filing as a material event.
26-01-2026
Cardlytics, Inc. filed a Form 8-K on January 26, 2026 (AccNo: 0001666071-26-000003, Size: 244 KB), reporting under Item 1.01 entry into a Material Definitive Agreement. No details on the core event, transaction value, parties involved, financial impacts, or strategic importance are disclosed in the provided information. Sector not specified.
26-01-2026
DevvStream Corp. filed a Form 8-K on 2026-01-26 (AccNo: 0001140361-26-002310, Size: 324 KB), reporting Items 1.01 (Entry into a Material Definitive Agreement), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing for a material event. No transaction details, financial metrics, entities, or scheduled events are disclosed in the provided information.
26-01-2026
VisionWave Holdings, Inc. filed a Form 8-K on January 26, 2026 (AccNo: 0001731122-26-000117, size 563 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. Sector not specified. No further details on the agreement, disclosures, or exhibits provided in the available information.
26-01-2026
XCF Global, Inc. filed a Form 8-K on 2026-01-26 (AccNo: 0001493152-26-003538, Size: 417 KB) reporting Items 1.01 (Entry into a Material Definitive Agreement), 3.02 (Unregistered Sales of Equity Securities), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on transaction value, share counts, counterparties, financial impacts, or strategic context provided in the summary. Sector is not specified.
26-01-2026
Atossa Therapeutics, Inc. filed a Form 8-K on January 26, 2026 (AccNo: 0001193125-26-021727, size: 196 KB), reporting under Item 3.03 (Material Modifications to Rights of Security Holders), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 5.07 (Submission of Matters to a Vote of Security Holders), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the modifications, amendments, vote outcomes, or any quantitative data provided in the summary. All transaction values, share counts, financial metrics, and other numbers are NOT_DISCLOSED.
26-01-2026
Paychex Inc filed a Form 8-K on January 26, 2026 (AccNo: 0001193125-26-021794, Size: 5 MB), reporting under Item 1.01 entry into a material definitive agreement, Item 1.02 termination of a material definitive agreement, and Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. This is a multi-item mandatory disclosure with no specific transaction details, dollar values, counterparties, or financial impacts provided in the summary. Sector is not specified.
26-01-2026
Global Interactive Technologies, Inc. filed an 8-K on January 26, 2026 (AccNo: 0001493152-26-003585), reporting entry into a material definitive agreement under Item 1.01, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details on the agreement, transaction value, or financial impacts provided. Sector not specified.
26-01-2026
Autolus Therapeutics plc filed a Form 8-K on January 26, 2026 (AccNo: 0001730463-26-000019, Size: 187 KB) reporting Item 1.01: Entry into a Material Definitive Agreement. No details on the agreement, transaction value, parties involved, or financial terms are disclosed in the provided information. Sector not specified.
26-01-2026
Stoke Therapeutics, Inc. filed a Form 8-K on 2026-01-26 (AccNo: 0001193125-26-022569, Size: 134 KB) reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. No specific transaction details, values, parties, or terms are disclosed in the provided filing summary.
26-01-2026
NEXTNRG, INC. filed a Form 8-K on 2026-01-26 (AccNo: 0001493152-26-003593, Size: 313 KB) reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction value, counterparties, financial impacts, or strategic rationale are disclosed. Sector not specified.
26-01-2026
TD SYNNEX CORP filed a Form 8-K on 2026-01-26 (AccNo: 0001628280-26-003407, Size: 804 KB) reporting entry into a Material Definitive Agreement under Item 1.01. Item 9.01 discloses Financial Statements and Exhibits. No specific transaction details, values, or other quantitative data are provided in the summary.
26-01-2026
Viasat Inc filed a Form 8-K on January 26, 2026 (AccNo: 0001193125-26-022564), reporting entry into a material definitive agreement (Item 1.01), creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), other events (Item 8.01), and financial statements/exhibits (Item 9.01). This is a multi-item filing with no specific transaction details, dollar values, or named counterparties disclosed in the provided summary. All quantitative and qualitative specifics are NOT_DISCLOSED.
26-01-2026
GOLD RESOURCE CORP filed a Form 8-K on 2026-01-26 (AccNo: 0001104659-26-006591, Size: 1 MB) reporting Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction value, parties involved, or financial impacts are disclosed in the provided summary. Sector not specified.
26-01-2026
GEO Group Inc filed a Form 8-K on January 26, 2026 (AccNo: 0001193125-26-022602, Size: 306 KB), reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or obligation under an off-balance sheet arrangement, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific transaction details, dollar values, counterparties, or terms disclosed in the provided summary. All quantitative metrics, named entities beyond the filer, and scheduled events are NOT_DISCLOSED.
26-01-2026
Lands' End, Inc. filed a Form 8-K on January 26, 2026 (AccNo: 0001104659-26-006603, Size: 2 MB), reporting under Item 1.01 entry into a material definitive agreement and under Item 3.02 unregistered sales of equity securities, with exhibits under Item 9.01. This is a multi-item mandatory filing as a material event. No specific transaction details, values, counterparties, or financial impacts are disclosed in the provided summary.
26-01-2026
Goldman Sachs BDC, Inc. filed a Form 8-K on 2026-01-26 (AccNo: 0001193125-26-022654, size 519 KB) reporting a Material Event under Item 1.01 for entry into a Material Definitive Agreement and Item 9.01 for Financial Statements and Exhibits. No specific details on the agreement, transaction value, parties involved, or financial impacts are disclosed in the provided filing summary. This is a multi-item mandatory filing as a business development company in the US equity markets.
26-01-2026
Nuo Therapeutics, Inc. filed a Form 8-K on January 26, 2026 (AccNo: 0001437749-26-002078), reporting entry into a material definitive agreement (Item 1.01), creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), and unregistered sales of equity securities (Item 3.02), with financial statements and exhibits attached (Item 9.01). No specific details on transaction terms, parties, dollar values, share counts, or strategic context are disclosed in the provided summary. Sector is not specified.
26-01-2026
Super Micro Computer, Inc. filed a Form 8-K on January 26, 2026 (AccNo: 0001375365-26-000004, Size: 38 MB), reporting multiple items including Item 1.01 (Entry into a Material Definitive Agreement), Item 5.08 (Shareholder Nominations Pursuant to Exchange Act Rule 14a-11), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, nominations, events, transaction values, or financial metrics provided in the summary. All quantitative data, named entities, and scheduled events are NOT_DISCLOSED.
26-01-2026
WhiteFiber, Inc. filed a Form 8-K on January 26, 2026 (AccNo: 0001213900-26-007740), reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 3.02 unregistered sales of equity securities, Item 8.01 other events, and Item 9.01 financial statements and exhibits. This is a multi-item mandatory filing with no specific transaction details, dollar values, parties, or impacts disclosed in the provided summary. All quantitative data such as transaction values, share counts, or percentages is NOT_DISCLOSED.
26-01-2026
Liminatus Pharma, Inc. filed an 8-K on 2026-01-26 (AccNo: 0001104659-26-006619, Size: 241 KB) reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No additional details on the delisting reason, transaction value, financial impacts, or strategic context are disclosed. Sector is not specified.
26-01-2026
SPLASH BEVERAGE GROUP, INC. filed a Form 8-K on 2026-01-26 (AccNo: 0001731122-26-000123) reporting Item 1.01 Entry into a Material Definitive Agreement, Item 3.02 Unregistered Sales of Equity Securities, and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific transaction details, dollar values, share counts, or financial impacts disclosed in the provided summary. All quantitative and qualitative details on the events are NOT_DISCLOSED.
26-01-2026
Copart Inc filed an 8-K on January 26, 2026 (AccNo: 0001193125-26-022730, Size: 1 MB), reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, with exhibits under Item 9.01. No specific transaction details, dollar values, counterparties, or numerical data are disclosed in the provided filing summary. This is a multi-item mandatory filing as a material event.
26-01-2026
Oncotelic Therapeutics, Inc. filed a Form 8-K on January 26, 2026 (AccNo: 0001493152-26-003606, Size: 303 KB), reporting entry into a material definitive agreement (Item 1.01), departure/election/appointment of directors/officers or compensatory arrangements (Item 5.02), and financial statements/exhibits (Item 9.01). This is a multi-item filing with no specific details on the agreement, personnel changes, transaction values, or financial impacts disclosed in the provided information. All quantitative metrics such as dollar values, share counts, or percentages are NOT_DISCLOSED.
26-01-2026
Energy Fuels Inc. filed an 8-K on January 26, 2026 (AccNo: 0001062993-26-000431, size: 8 MB), reporting entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). This is a multi-item mandatory filing with no specific transaction details, dollar values, entities, or financial metrics disclosed in the provided summary. Sector is not specified.
26-01-2026
DAXOR CORP filed Form 8-K on 2026-01-26 (AccNo: 0001493152-26-003615, Size: 804 KB) reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on the agreement, events, transaction value, parties, or financial impacts are disclosed in the provided information. This is a multi-item filing indicating potentially significant developments.
26-01-2026
Mount Logan Capital Inc. filed a Form 8-K on 2026-01-26 reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant), with Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific transaction details, dollar values, parties, or terms disclosed in the provided summary. Sector is not specified.
26-01-2026
RAYONIER ADVANCED MATERIALS INC. filed a Form 8-K on January 26, 2026 (AccNo: 0001597672-26-000006, size: 197 KB) reporting under Item 7.01 Regulation FD Disclosure. No specific details on the disclosure content, transaction values, financial impacts, or scheduled events are provided in the filing summary. Sector not specified.
26-01-2026
Aethlon Medical Inc filed a Form 8-K on January 26, 2026 (AccNo: 0001683168-26-000528, Size: 231 KB), reporting entry into a Material Definitive Agreement under Item 1.01 and including Financial Statements and Exhibits under Item 9.01. No specific details on the agreement, transaction value, parties involved, or financial impacts are disclosed in the provided information. This is a multi-item filing for a material event in an unspecified sector.
26-01-2026
USBC, Inc. filed a Form 8-K on January 26, 2026 (AccNo: 0001654954-26-000601, Size: 323 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. This is a multi-item mandatory filing for material events with no specific details on the agreement, transaction value, or financial impacts provided in the summary. Sector is not specified.
26-01-2026
SkyWater Technology, Inc. filed a Form 8-K on 2026-01-26 (AccNo: 0001193125-26-022750) disclosing entry into a material definitive agreement under Item 1.01 and financial statements and exhibits under Item 9.01. This is a multi-item mandatory filing within the required 4-business-day window. No details on the agreement, transaction value, or exhibits are provided.
26-01-2026
AmpliTech Group, Inc. filed a Form 8-K on 2026-01-26 (AccNo: 0001493152-26-003631, Size: 941 KB) reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, personnel changes, transaction values, or financial metrics provided. Sector is not specified.
26-01-2026
OLB Group, Inc. filed a Form 8-K on January 26, 2026 (AccNo: 0001213900-26-007800, size 711 KB), reporting entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No details on transaction parties, values, share counts, financial impacts, or strategic context are disclosed in the provided information. Sector not specified.
26-01-2026
NKGen Biotech, Inc. filed a Form 8-K on January 26, 2026 (AccNo: 0001213900-26-007794, Size: 285 KB), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, transaction value, counterparties, or financial impacts disclosed in the provided summary. Sector is NOT_DISCLOSED.
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 50 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC